Status:

UNKNOWN

Comparison of the Pharmacokinetics of Three Generic Medications and Their Respective Brand Preparations

Lead Sponsor:

University of Ottawa

Conditions:

Healthy

Eligibility:

MALE

18-50 years

Phase:

PHASE1

Brief Summary

Generic describes a pharmaceutical product that does not have a brand name or trademark. Generic medications should be the equivalent of brand medications. Only their price should be different. The ac...

Eligibility Criteria

Inclusion

  • Healthy volunteers (absence of diseases: psychiatric, physical, neurological, metabolic,...)

Exclusion

  • Psychiatric disorder
  • Hepatic disease
  • Renal disease
  • Gastrointestinal disease
  • Hematological disease
  • Smokers
  • Physical and/or neurological disease
  • Positive urine drug screen
  • Abnormal blood pressure
  • Abnormal Electrocardiogram
  • Abnormal urine/blood analysis (sodium, potassium, chloride, creatinine, urea, ALT, AST, total protein, glucose, and TSH)
  • Taking medication
  • Have donated 50 mL to 499 mL whole blood within 30 days and more than 499 mL whole blood within 56 days preceding entry into this study

Key Trial Info

Start Date :

July 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2011

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01400165

Start Date

July 1 2011

End Date

December 1 2011

Last Update

July 22 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Ottawa, Institute of Mental Health Research

Ottawa, Ontario, Canada, K1Z-7K4